Document is current

Any future updates will be listed below

Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells

Crossref DOI link: https://doi.org/10.1186/s12920-022-01309-6

Published Online: 2022-07-08

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark